Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avidekel Oil for Hidradenitis Suppurativa
NCT03929835Phase 2Withdrawn
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hidradenitis suppurativa (HS) comparing Avidekel Oil with Placebo (2 arms). Primary endpoint: Clinical response at Week 8. Planned start Sep 2020; status: withdrawn.
02
Drugs
Avidekel
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT03929835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03929835.